Photo courtesy: The Indian Express
New Delhi: Countries like France, Italy and Belgium have asked the hospitals here to stop the use of anti-malaria drug Hydroxychloroquine to treat COVID-19 patients.
The medication was halted amid health safety of the infected patients.
The World Health Organization (WHO) also paused trials of the drug after a report published in the Lancet Journal claimed the medication was harming the patients.
Following the health body’s instructions, the three hardest-hit countries by the coronavirus cancelled the authorization of the drug.
Meanwhile, the countries will continue to carry out clinical trials of the drug outside human use. The trials will also expose the potential risks of using the drug and check its effectiveness in treating the virus.
Also Read: Anti-Malarial Drug Hydroxychloroquine Increases Risk Of Corona Deaths In US: Study
Bhubaneswar: Odisha witnessed no let-up in heatwave condition on Saturday when 25 places registered temperature…
New Delhi: Over three dozen candidates who appeared in Joint Entrance Exam (JEE) Main 2024 have…
Bhubaneswar: Seven of the 37 candidates (19 per cent) in fray for the first phase…
Bhubaneswar: The Commissionerate Police has made elaborate security arrangements in Bhubaneswar during Prime Minister Narendra…
Chennai: A Tamil Nadu Congress leader had been missing since Thursday. On Saturday, his burnt…
Bhubaneswar: Santrupt Misra (58) of BJD is the richest while Pramila Pujari (25) of Socialist…
Bhubaneswar: More than 4,000 voters have opted for "home voting" in first phase of dual…
New Delhi: Days after stepping down as the Delhi Congress chief, Arvinder Singh Lovely on…